Helius Medical Technologies, Inc. Announces Participation of Oregon Health & Science University in its Therapeutic Experience Program
– Third Center of Excellence added in multi-center, company-sponsored, open label observational interventional trial to evaluate the impact of subjects’ adherence to PoNS® therapy for gait improvement in Multiple Sclerosis – NEWTOWN, Pa., Nov. 08, 2022 (GLOBE NEWSWIRE) – Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, […]
Helius to Showcase Innovative PoNS Device at ACRM’s 2022 Conference – Demonstrating the Power of Neuromodulation to Help People with MS Improve their Gait
Physical Therapists Who Visit Booth 512 Can Sign Up for Free Online PoNS Therapy™ Training NEWTOWN, Pa., Nov. 03, 2022 (GLOBE NEWSWIRE) – Helius Medical Technologies (NASDAQ: HSDT) will showcase its innovative new Portable Neuromodulation Stimulator (PoNS®) at the 99th annual American Congress of Rehabilitation Medicine (ACRM) Conference, held November 8-11 in Chicago. Visitors to […]
Helius Salutes Physical Therapists for Their Role in Helping People with MS Improve Their Gait
Company Spotlights its Appreciation to Physical Therapists Trained in its Innovative PoNS Therapy™ in Honor of National Physical Therapy Month NEWTOWN, Pa., Oct. 13, 2022 (GLOBE NEWSWIRE) – National Physical Therapy Month (NPTM) comes every October, but this one is particularly meaningful to Helius Medical Technologies (NASDAQ: HSDT): This year, the company has trained a […]
Helius Medical Technologies, Inc. Announces Online Training for PoNS Therapy™
– Training for physical therapists treating patients with multiple sclerosis (MS) is now available on demand – NEWTOWN, Pa., July 12, 2022 (GLOBE NEWSWIRE) – Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced the launch of its online training module for physical therapists seeking to […]
Helius Medical Technologies, Inc. Presents Poster at the 2022 Consortium of Multiple Sclerosis Centers (“CMSC”) Annual Meeting
– Study finds significant improvement in gait deficit in multiple sclerosis patients using translingual neurostimulation (“PoNS Therapy®”) combined with a therapeutic exercise program – – Poster was one of ten rehabilitation research presentations nominated for the Labe C. Scheinberg Award recognizing the platform or poster, in each therapeutic category, that has the greatest impact in advancing the care […]
Helius Medical Technologies, Inc. Announces Launch of Patient Therapy Access Program for PoNS®
New program seeks to expand access to patients suffering from multiple sclerosis (MS) NEWTOWN, Pa., June 01, 2022 (GLOBE NEWSWIRE) – Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced the launch of its Patient Therapy Access Program (“PTAP”), which will provide qualifying patients access to […]
Helius Medical Announces Poster to Be Presented at the Consortium for Multiple Sclerosis Centers (CMSC) Annual Conference
NEWTOWN, Pa., May 31, 2022 (GLOBE NEWSWIRE) – Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced that an abstract highlighting real-world data, which shows the impact of translingual neurostimulation as a rehabilitation therapy to improve gait in people with multiple sclerosis (MS), has been […]
Helius Medical Technologies, Inc. Reports First Quarter 2022 Financial Results and Provides Update on U.S. Commercial Launch of PoNS®
– Company to host call at 9:00am today with CEO, CFO, CMO and VP Sales & Marketing – NEWTOWN, Pa., May 12, 2022 (GLOBE NEWSWIRE) – Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today reported financial results for the quarter ended March 31, 2022. First Quarter and […]
Helius Medical Technologies, Inc. Fulfills First U.S. Prescriptions for PoNS®
– First patients have purchased PoNS devices to initiate PoNS Therapy –– Nineteen PoNS device prescriptions have been written in the U.S. since recent commercial launch – NEWTOWN, Pa., April 27, 2022 (GLOBE NEWSWIRE) – Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced the fulfillment […]
Helius Medical Technologies, Inc. Introduces Device in U.S. To Help Multiple Sclerosis Patients Improve Walking Ability
– Breakthrough technology for MS patients helps patients with gait deficit – Portable Neuromodulation Stimulator (PoNS®) is an innovative non-surgical medical device that includes a controller and a mouthpiece – Available directly to patients by prescription, used in conjunction with physical therapy NEWTOWN, Pa., April 26, 2022 (GLOBE NEWSWIRE) – Helius Medical Technologies, Inc. (Nasdaq: […]
